HNSA — Hansa Biopharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Hansa Biopharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	889	1,496	732	405	701
Net Total Accounts Receivable
Net Total Receivables	32.3	65	91.8	160	89.4
Total Inventory
Prepaid Expenses
Total Current Assets	942	1,605	855	585	797
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.7	35.8	27.1	17.9	13.3
Net Intangible Assets
Long Term Notes Receivable
Total Assets	1,013	1,687	1,018	801	1,167
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	171	265	321	256	411
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	255	1,084	1,186	1,390	1,251
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	758	603	-168	-590	-84.1
Total Liabilities & Shareholders' Equity	1,013	1,687	1,018	801	1,167
Total Common Shares Outstanding